• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性阴道恶性肿瘤的特征与生存情况:基于德国全国癌症登记数据的分析

Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data.

作者信息

Forner Dirk Michael

机构信息

Department of Gynaecology, Gynaecologic Oncology and Obstetrics, Evangelisches Krankenhaus Köln Kalk, Buchforststrasse 2, 51103, Köln, Germany.

出版信息

J Cancer Res Clin Oncol. 2023 Mar;149(3):1115-1122. doi: 10.1007/s00432-022-03982-7. Epub 2022 Mar 21.

DOI:10.1007/s00432-022-03982-7
PMID:35314872
Abstract

BACKGROUND

Vaginal neoplasms are rare. To study the survival of patients depending on tumour characteristics and age, the data from the national cancer registries in Germany were analysed.

METHODS

In a retrospective analysis, data from 2006 to 2015 on disease stage, survival, and factors that might affect prognosis were analysed.

RESULTS

Altogether, out of 4004 datasets, 2194 were deemed adequate to be included in the analysis. Overall survival at 5 years (5YSR) and relative survival (5RSR) were 48.6% (95%CI 45.4-52.1%) and 58.7% (95%CI 55.3-61.2%) for carcinomas, but significantly worse at 20.2% (95%CI 8.3-32.0%) and 24.2% (95%CI 16.4-32.0%) for melanomas and 38.3% (95%CI 23.3-53.5%) and 44.4% (95%CI 31.5-56.8%) for sarcomas. 5YSR and 5RSR correlated significantly with FIGO stages (5YSR: 66.9-10.1%; 5RSR: 81.7-11.9%, p = 0.04). Furthermore, survival depended on the absence of LN metastases (5RSR: 59.1% vs. 38.0%, p < 0.001), and the tumour grading had an influence (5RSR: 83.7-52.1%). We also noted that prognosis was worse for older patients ≥75 years (5RSR:51.2%) than for patients <55 years (62.2%) and 55-74 years of age (61.6%).

CONCLUSION

Unless LN metastases, local advanced tumours and G3 grading are associated with a worse prognosis. Relative survival of older patients decreases, perhaps indicating that treatment compromises have been made.

摘要

背景

阴道肿瘤较为罕见。为了根据肿瘤特征和年龄研究患者的生存率,对德国国家癌症登记处的数据进行了分析。

方法

在一项回顾性分析中,分析了2006年至2015年有关疾病分期、生存率及可能影响预后因素的数据。

结果

在4004个数据集中,共有2194个被认为适合纳入分析。癌的5年总生存率(5YSR)和相对生存率(5RSR)分别为48.6%(95%CI 45.4 - 52.1%)和58.7%(95%CI 55.3 - 61.2%),但黑色素瘤的5YSR和5RSR显著更差,分别为20.2%(95%CI 8.3 - 32.0%)和24.2%(95%CI 16.4 - 32.0%),肉瘤的5YSR和5RSR分别为38.3%(95%CI 23.3 - 53.5%)和44.4%(95%CI 31.5 - 56.8%)。5YSR和5RSR与国际妇产科联盟(FIGO)分期显著相关(5YSR:66.9 - 10.1%;5RSR:81.7 - 11.9%,p = 0.04)。此外,生存率取决于有无淋巴结转移(5RSR:59.1%对38.0%,p < 0.001),且肿瘤分级有影响(5RSR:83.7 - 52.1%)。我们还注意到,≥75岁的老年患者预后比<55岁(62.2%)和55 - 74岁(61.6%)的患者更差(5RSR:51.2%)。

结论

除非有淋巴结转移、局部晚期肿瘤和G3分级与预后较差相关。老年患者的相对生存率降低,这可能表明在治疗上做出了妥协。

相似文献

1
Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data.原发性阴道恶性肿瘤的特征与生存情况:基于德国全国癌症登记数据的分析
J Cancer Res Clin Oncol. 2023 Mar;149(3):1115-1122. doi: 10.1007/s00432-022-03982-7. Epub 2022 Mar 21.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.前哨淋巴结活检后行局部原发性皮肤黑色素瘤淋巴结清扫术。
Cochrane Database Syst Rev. 2015 May 16;2015(5):CD010307. doi: 10.1002/14651858.CD010307.pub2.
8
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

本文引用的文献

1
Vaginal intraepithelial neoplasia in patients after total hysterectomy.全子宫切除术后患者的阴道上皮内瘤变
Curr Probl Cancer. 2021 Jun;45(3):100687. doi: 10.1016/j.currproblcancer.2020.100687. Epub 2020 Dec 4.
2
The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation.近距离放疗推量和放疗治疗时间对接受根治性放化疗的阴道癌患者生存的影响。
Brachytherapy. 2021 Jan-Feb;20(1):75-84. doi: 10.1016/j.brachy.2020.08.020. Epub 2020 Sep 29.
3
Management and outcomes of primary vaginal Cancer.
原发性阴道癌的治疗与结局。
Gynecol Oncol. 2020 Nov;159(2):456-463. doi: 10.1016/j.ygyno.2020.08.036. Epub 2020 Sep 22.
4
Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - A nationwide population-based study.丹麦阴道鳞状细胞癌和高级阴道上皮内瘤变发病率和生存率的时间趋势:一项全国性基于人群的研究。
Gynecol Oncol. 2020 Sep;158(3):734-739. doi: 10.1016/j.ygyno.2020.05.683. Epub 2020 Jun 19.
5
Primary vaginal malignant melanoma: A rare entity with review of literature.原发性阴道恶性黑色素瘤:一种罕见实体并文献复习
J Cancer Res Ther. 2019 Oct-Dec;15(6):1392-1394. doi: 10.4103/jcrt.JCRT_893_15.
6
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
7
Cancer of the vagina.阴道癌。
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:14-21. doi: 10.1002/ijgo.12610.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry: Long-term analysis from a clinical viewpoint.利用日本大阪基于人群的癌症登记数据对阴道癌进行的描述性流行病学研究:从临床角度进行的长期分析。
Medicine (Baltimore). 2017 Aug;96(32):e7751. doi: 10.1097/MD.0000000000007751.
10
Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.宫颈上皮内瘤变 3 级后 HPV 相关癌前病变和癌长期持续高风险:基于人群的队列研究。
J Clin Oncol. 2017 Aug 1;35(22):2542-2550. doi: 10.1200/JCO.2016.71.4543. Epub 2017 May 25.